Chemistry & Physics

Dr. Brent Feske receives internal grant to extend his work in biocatalysis.
 
Dr. Brent Feske, chemistry, has been awarded $943 from the Armstrong Research and Scholarship Committee to support his research.  The project, titled “Biocatalysis: Utilizing Engineered E. coli towards Pharmaceutical-grade Compounds” is designed to investigate greener adaptations of important chemical compounds as potential pharmaceuticals.  Biocatalysis involves reactions with enzymes or living cells and is advantageous over standard chemical practices because it occurs at moderate temperatures, in water and uses biomolecules  rather than toxic solvents, high temperatures and potentially hazardous catalysts.